Generics will continue their domination on the pharmaceutical market in Central and Eastern Europe until 2011 - November 2009

The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according to our latest report entitled “Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”.

To receive a full version of this FREE article, please fill in the form below. The article (in a PDF file

) will be sent to your e-mail address.

None of this information will be disclosed to third parties.
To be assured that we take your privacy seriously, please read our Privacy Policy.

Please fill out all the fields correctly. Information will only be provided if forms are adequately completed.

Email:

In order to make sure you receive our information, please add our email address: info@pmrcorporate.com to the list of safe sources in your company. Please contact your IT department for details. Thank you.

Choose sector of interest: (You must specify at least one sector)

construction:

retail:

pharma:

it & telecom:

general economy:

Additional:
(specify)

Please read our Privacy Policy.